Ablynx
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Belgium
- Registered address
- Technologiepark-Zwijnaarde 21 Gent,, ZWIJNAARDE, 9052, Belgium (BEL)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3008915297 · DUNS 372000096
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-05-24
- VAIDrug Quality Assurance2021-02-09
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- caplacizumabGenzyme Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.